All Companies
LLYCongressional Stock Trades
Eli Lilly & Co.
Pharmaceutical Preparations
Congressional stock trades in Eli Lilly & Co. (LLY) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
53
Politicians Trading
22
Last Traded
Jul 10, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Alan ArmstrongR | Jul 21, 2026 | Mar 27, 2026 | Sell | $1,001 - $15,000 | +31.28% |
| John BoozmanR | Dec 8, 2025 | Nov 21, 2025 | Sell | $1,001 - $15,000 | +8.80% |
| Tommy TubervilleR | May 15, 2025 | Apr 15, 2025 | Sell | $15,001 - $50,000 | +52.27% |
| Ron WydenD | Feb 21, 2025 | Feb 10, 2025 | Sell | $50,001 - $100,000 | +32.69% |
Price History
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.